Literature DB >> 30094210

Incomplete revascularization: what the surgeon needs to know.

Dror B Leviner1, Gianluca Torregrossa1, John D Puskas1.   

Abstract

For many years, the concept of "complete revascularization" (CR) was considered an absolute truth in coronary surgery with improved long-term survival and a lower rate of reintervention. This was derived from early publications which showed a survival benefit for patients undergoing coronary artery bypass grafting (CABG) who received CR. Many advances in the field of coronary revascularization have been made in the years that passed since those publications, including more frequent use of percutaneous coronary intervention (PCI) in patients with multivessel disease (MVD). This has led some to question the importance of CR and raise the option of "reasonable incomplete revascularization" (IR) for selected patients. The definition of CR is variable in the literature with the two most common definitions being an anatomical (revascularization of all coronary segments with stenosis and larger than a predefined size) and a functional definition (where revascularization is considered complete if all ischemic and viable territories are reperfused). No randomized control trials have been conducted to compare complete versus IR, and a significant proportion of data is based on post hoc analysis of data from randomized control trials and registries. Multiple studies have proven that CR is achieved more frequently with CABG then with PCI. A review of the available data from the past three to four decades shows a trend toward improved results with CR, regardless of the reperfusion strategy chosen. This should impact the heart team discussion when choosing a revascularization strategy and impact the surgical decision making while preforming CABG. IR can be part of a hybrid revascularization strategy or be reserved for rare cases where the cost of achieving CR much outweighs the benefit.

Entities:  

Keywords:  Coronary artery bypass grafting (CABG); hybrid coronary revascularization (HCR); incomplete revascularization (IR); off pump coronary artery bypass grafting (OPCAB); percutaneous coronary intervention (PCI)

Year:  2018        PMID: 30094210      PMCID: PMC6082780          DOI: 10.21037/acs.2018.06.07

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN: 2225-319X


  27 in total

1.  What constitutes optimal surgical revascularization? Answers from the Bypass Angioplasty Revascularization Investigation (BARI).

Authors:  Thomas J Vander Salm; Kevin E Kip; Robert H Jones; Hartzell V Schaff; Richard J Shemin; Gabriel S Aldea; Katherine M Detre
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

2.  The effect of completeness of revascularization on event-free survival at one year in the ARTS trial.

Authors:  Marcel J B M van den Brand; Benno J W M Rensing; Marie-angèle M Morel; David P Foley; Vincent de Valk; Arno Breeman; Harry Suryapranata; Maximiliaan M P Haalebos; William Wijns; Francis Wellens; Rafael Balcon; Patrick Magee; Expedito Ribeiro; Enio Buffolo; Felix Unger; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

3.  2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  L David Hillis; Peter K Smith; Jeffrey L Anderson; John A Bittl; Charles R Bridges; John G Byrne; Joaquin E Cigarroa; Verdi J Disesa; Loren F Hiratzka; Adolph M Hutter; Michael E Jessen; Ellen C Keeley; Stephen J Lahey; Richard A Lange; Martin J London; Michael J Mack; Manesh R Patel; John D Puskas; Joseph F Sabik; Ola Selnes; David M Shahian; Jeffrey C Trost; Michael D Winniford
Journal:  Circulation       Date:  2011-11-07       Impact factor: 29.690

4.  Influence of on-pump versus off-pump techniques and completeness of revascularization on long-term survival after coronary artery bypass.

Authors:  Omar M Lattouf; Vinod H Thourani; Patrick D Kilgo; Michael E Halkos; Kim T Baio; Richard Myung; William A Cooper; Robert A Guyton; John D Puskas
Journal:  Ann Thorac Surg       Date:  2008-09       Impact factor: 4.330

5.  Incomplete revascularization during OPCAB surgery is associated with reduced mid-term event-free survival.

Authors:  Massimo Caputo; Barnaby C Reeves; Chanaka Rajkaruna; Hazaim Awair; Gianni D Angelini
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

6.  The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial.

Authors:  Vasim Farooq; Patrick W Serruys; Hector M Garcia-Garcia; Yaojun Zhang; Christos V Bourantas; David R Holmes; Michael Mack; Ted Feldman; Marie-Claude Morice; Elisabeth Ståhle; Stefan James; Antonio Colombo; Roberto Diletti; Michail I Papafaklis; Ton de Vries; Marie-Angèle Morel; Gerrit Anne van Es; Friedrich W Mohr; Keith D Dawkins; Arie-Pieter Kappetein; Georgios Sianos; Eric Boersma
Journal:  J Am Coll Cardiol       Date:  2012-12-19       Impact factor: 24.094

7.  Off-pump coronary artery surgery for reducing mortality and morbidity: meta-analysis of randomized and observational studies.

Authors:  Duminda N Wijeysundera; W Scott Beattie; George Djaiani; Vivek Rao; Michael A Borger; Keyvan Karkouti; Robert J Cusimano
Journal:  J Am Coll Cardiol       Date:  2005-09-06       Impact factor: 24.094

8.  Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) Registry.

Authors:  M R Bell; B J Gersh; H V Schaff; D R Holmes; L D Fisher; E L Alderman; W O Myers; L S Parsons; G S Reeder
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

9.  Alternative approach to multivessel coronary disease with integrated coronary revascularization.

Authors:  M Zenati; H A Cohen; B P Griffith
Journal:  J Thorac Cardiovasc Surg       Date:  1999-03       Impact factor: 5.209

10.  Importance of complete revascularization in performance of the coronary bypass operation.

Authors:  E L Jones; J M Craver; R A Guyton; D K Bone; C R Hatcher; N Riechwald
Journal:  Am J Cardiol       Date:  1983-01-01       Impact factor: 2.778

View more
  8 in total

Review 1.  Therapeutic angiogenesis with exosomal microRNAs: an effectual approach for the treatment of myocardial ischemia.

Authors:  Toktam Moghiman; Bita Barghchi; Seyed-Alireza Esmaeili; Mahmoud Mohammadzadeh Shabestari; Seyedeh Samaneh Tabaee; Amir Abbas Momtazi-Borojeni
Journal:  Heart Fail Rev       Date:  2021-01       Impact factor: 4.214

2.  Gender and coronary artery bypass grafting in cardiogenic shock.

Authors:  Marcin P Szczechowicz; Sabreen Mkalaluh; Saeed Torabi; Jerry Easo; Matthias Karck; Alexander Weymann
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-08-12

3.  Efficient cardiac gene transfer and early-onset expression of a synthetic adeno-associated viral vector, Anc80L65, after intramyocardial administration.

Authors:  Michael G Katz; Yoav Hadas; Rasheed A Bailey; Shahood Fazal; Adam Vincek; Sophia J Madjarova; Nataly Shtraizent; Luk H Vandenberghe; Efrat Eliyahu
Journal:  J Thorac Cardiovasc Surg       Date:  2021-06-17       Impact factor: 5.209

Review 4.  Percutaneous Coronary Intervention with Stenting versus Coronary Artery Bypass Grafting in Stable Coronary Artery Disease.

Authors:  Ian C Glenn; Gabriele M Iacona; Abeel A Mangi
Journal:  Int J Angiol       Date:  2021-08-31

5.  Angiogenic stem cell delivery platform to augment post-infarction neovasculature and reverse ventricular remodeling.

Authors:  Hye Sook Shin; Akshara Thakore; Yuko Tada; Albert J Pedroza; Gentaro Ikeda; Ian Y Chen; Doreen Chan; Kevin J Jaatinen; Shin Yajima; Eric M Pfrender; Masashi Kawamura; Phillip C Yang; Joseph C Wu; Eric A Appel; Michael P Fischbein; YJoseph Woo; Yasuhiro Shudo
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

6.  Impacts of incomplete revascularization following off-pump coronary artery bypass grafting on clinical outcomes of patients with triple-vessel lesions: insights from a single-center study of propensity-matched data.

Authors:  Qiang Ji; Yun Zhao; Kai Zhu; Kai Song; Jinqiang Shen; Yulin Wang; Ye Yang; Wenjun Ding; Limin Xia; Chunsheng Wang
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

7.  Clinical potential of angiogenic therapy and cellular reprogramming.

Authors:  Christopher T Ryan; Vivek Patel; Todd K Rosengart
Journal:  JTCVS Open       Date:  2021-03-18

8.  Reply: The incomplete puzzle of complete revascularization.

Authors:  Thin X Vo; Marc Ruel
Journal:  JTCVS Open       Date:  2021-09-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.